Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease
Abstract Background Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States with no effective treatment. The current diagnostic method, spirometry, does not accurately reflect the severity of COPD disease status. Therefore, there is a pressing unmet medi...
Main Authors: | Ding Liu, Maureen Meister, Shiying Zhang, Chi-In Vong, Shuaishuai Wang, Ruixie Fang, Lei Li, Peng George Wang, Pierre Massion, Xiangming Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-020-01507-9 |
Similar Items
-
Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease
by: Zhou J, et al.
Published: (2020-03-01) -
Mining for Lung Cancer Biomarkers in Plasma Metabolomics Data
by: Johnsson, Anna
Published: (2010) -
The 1H NMR serum metabolomics response to a two meal challenge: a cross-over dietary intervention study in healthy human volunteers
by: Millie Rådjursöga, et al.
Published: (2019-04-01) -
The most frequent comorbidities at patients with the chronic obstructive pulmonary disease
by: Krdžić Biljana, et al.
Published: (2018-01-01) -
<sup>1</sup>H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages
by: Andrea Casadei-Gardini, et al.
Published: (2020-01-01)